Aukelien C. Dimitriu-Leen

Aukelien C. Dimitriu-Leen

Auto-generated profile, based on publicly available information

Aukelien C. Dimitriu-Leen

Department of Cardiology, Radboud University Medical Center , Geert Grooteplein Zuid 10, Nijmegen, GA 6525

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ARAlexander R. van Rosendael
Alexander R. van Rosendael
LDLaurien A. Daniëls
Laurien A. Daniëls
ADAukelien C. Dimitriu-Leen
Aukelien C. Dimitriu-Leen
JSJeff M. Smit
Jeff M. Smit
PRPhilippe Rosendael
Philippe Rosendael
ASArthur J.H.A. Scholte
Arthur J.H.A. Scholte

1 March 2018 in The American Journal of Cardiology
Verified
Journal Article
Closed access
ADAukelien C. Dimitriu-Leen
Aukelien C. Dimitriu-Leen
MHMaaike P.J. Hermans
Maaike P.J. Hermans
ARAlexander R. van Rosendael
Alexander R. van Rosendael
EZErik W. van Zwet
Erik W. van Zwet
BHBas L. van der Hoeven
Bas L. van der Hoeven
ASArthur J.H.A. Scholte
Arthur J.H.A. Scholte

21 January 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
CCC. Crooijmans
C. Crooijmans
TJTijn P. J. Jansen
Tijn P. J. Jansen
JMJoan G. Meeder
Joan G. Meeder
Paradies ValeriaParadies Valeria
Paradies Valeria
AVAnnemiek de Vos
Annemiek de Vos
FNFor Nl‐Cft
For Nl‐Cft
Background: A coronary function test (CFT) is the recommended diagnostic test to identify coronary vasomotor dysfunction as a cause of symptoms in patients with angina and nonobstructive coronary arteries (ANOCA). Acetylcholine is the commonly used pharmacological agent for spasm provocation. We aimed to investigate an association between severity of symptoms and provocative acetylcholine dose. Methods and Results: We included ANOCA patients undergoing clinically indicated CFT from the Netherlands Registry of Invasive Coronary Vasomotor Function Testing: NL‐CFT. Patients with epicardial spasm (n=251) were divided according to acetylcholine spasm triggering dose: low (2–20 mcg, EpiLOW), middle (100 mcg, EpiMIDDLE) or high (200 mcg, EpiHIGH). Patients with microvascular spasm (n=157) were analyzed irrespective of triggering dose. The patient groups were compared to each other and to a control group with negative CFT results (n=101). We assessed mean Seattle Angina Questionnaire angina frequency and summary scores at baseline and follow‐up and the proportion of patients improving or deteriorating. An inverse relationship between provocation dosage and angina frequency at baseline was found in epicardial spasm: the lower the triggering dose, the more frequently patients experienced angina (EpiLOW 48±20, EpiMIDDLE 53±21, EpiHIGH 57±19, microvascular spasm 61±21, controls 64±21, overall P =0.003). A trend was seen toward most patients improving in the high triggering dose group, and most patients deteriorating in the low triggering dose group. Conclusions: A significant dose‐dependent relationship between spasm provocation and anginal complaints exists. Acetylcholine provocation dose could be incorporated as a risk stratification factor or surrogate outcome in future clinical trials. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06083155.

1 June 2026 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
FAFleur W. Adriaansen
Fleur W. Adriaansen
CCCaïa Crooijmans
Caïa Crooijmans
TJTijn P.J. Jansen
Tijn P.J. Jansen
BYBehruz Yosofi
Behruz Yosofi
JMJoan G. Meeder
Joan G. Meeder
FNFor Nl-Cft
For Nl-Cft
BACKGROUND: Coronary vasomotor dysfunction is diagnosed by a coronary function testing (CFT). However, protocols vary, and the influence of access site and concomitant vasodilator medication on the diagnostic yield and safety of CFT is unclear. This study assessed the diagnostic yield and safety of CFT by radial access with intraarterial calcium channel blockers compared with CFT by femoral access. METHODS: Data were obtained from the Netherlands Registry of Invasive Coronary Vasomotor Function Testing, a Dutch multicenter collaboration on CFT. Patients who underwent CFT between December 2020 and July 2025 were included. RESULTS: A total of 1885 patients were included, 1436 (76.2%) with primary radial access and 380 (20.2%) with primary femoral access. In 69 (3.7%) patients conversion from radial to femoral access was necessary. The conversion group was analyzed separately. The total diagnostic yield of coronary vasomotor dysfunction was 78.5%. There was no significant difference in the prevalence of coronary vasomotor dysfunction between patients with primary radial versus femoral access (79.2% versus 75.3%; P =0.1). There was also no difference in total diagnostic yield between the group without conversion and the conversion group (78.4% versus 82.6%; P =0.4); however, spasm was more prevalent in the conversion group (67.7% versus 79.4%; P =0.04). There were no differences in CFT complication rates between groups. CONCLUSIONS: Primary radial access with routine administration of calcium channel blockers was not associated with a lower diagnostic yield in CFT than primary femoral access. Procedural safety was comparable.

31 August 2026 in European Heart Journal
Verified
Journal Article
Open access
CCCaïa Crooijmans
Caïa Crooijmans
FAFleur W Adriaansen
Fleur W Adriaansen
JMJoan G Meeder
Joan G Meeder
MBMarcel A. M. Beijk
Marcel A. M. Beijk
BYBehruz Yosofi
Behruz Yosofi
NFN Fagel
N Fagel
Background and Aims: Comprehensive evaluation by invasive coronary function test (CFT) of patients with angina and non-obstructive coronary artery disease is recommended in the current guidelines. The prognosis of patients with CFT-proven coronary vasomotor dysfunction (CVDys) is less well-known. Methods: Patients that provided consent for the previously published NL-CFT registry who underwent clinically indicated invasive CFT between 1 February 2019 and 1 June 2024 were included. Patients with CVDys, defined as an abnormal spasm provocation test and/or microvascular functional assessment, were compared to patients with normal CFT. The primary outcome of major adverse cardiovascular events and emergency room visits for angina (MACE-EA) was defined as a composite of all-cause death, acute coronary syndrome, stroke/transient ischaemic attack, revascularization, repeat angiography without intervention, heart failure hospitalizations, and unplanned hospitalizations or emergency room visits due to angina. Results: In total, 1355 patients were included. In 79.8%, CFT was abnormal, and vasospasm was the most prevalent endotype. In 1252 patients, follow-up of clinical events was complete. During a mean follow-up of 33 ± 13 months, CVDys patients had almost double the number of primary outcome events compared with patients with a normal CFT (31.2% vs 16.8%, P < .001), driven by emergency care visits for angina. Secondary clinical endpoints including death, myocardial infarction, stroke, or revascularization were low and comparable between the groups. Conclusions: The long-term risk of MACE-EA is doubled in ANOCA patients with CFT-confirmed CVDys compared with normal CFT results. Events are dominated by emergency room visits due to angina, illustrating the high disease burden of CVDys. Their (angina-related) health status is significantly worse at follow-up.

15 June 2026 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
DSDinah L van Schalkwijk
Dinah L van Schalkwijk
MHMariëlle J Hartzema-Meijer
Mariëlle J Hartzema-Meijer
PDPeter Damman
Peter Damman
BSBart Scheenstra
Bart Scheenstra
MHMelina C Den Haan
Melina C Den Haan
Gabriela Lima de Melo GhisiGabriela Lima de Melo Ghisi
Gabriela Lima de Melo Ghisi
Aims: Angina with non-obstructive coronary arteries (ANOCA) is associated with impaired quality of life, and cardiac rehabilitation (CR) may be a promising non-pharmacological treatment option. This scoping review aimed to map how CR for patients with ANOCA is described in the literature, including programme components, delivery characteristics, reported outcomes, and research gaps. Methods and results: A scoping review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. A comprehensive search of seven electronic databases was performed from inception to 30 September 2025. Studies reporting CR interventions in adults with ANOCA or related endotypes were included. Data were charted using the Template for Intervention Description and Replication checklist and synthesized descriptively. Qualitative findings were organized using a socio-ecological model. Methodological quality was assessed descriptively using the Mixed Methods Appraisal Tool. The database search yielded 14 072 records, of which 26 studies were included. Cardiac rehabilitation interventions were generally safe and well tolerated, with high adherence rates. Patient-reported outcomes consistently improved, particularly angina symptoms, quality of life, and psychological well-being, while effects on physiological outcomes were heterogeneous. Exercise training was the most common intervention component, often individualized and combined with psychosocial therapies. Qualitative findings highlighted unmet needs related to education, psychological support, validation, and flexible, tailored programme delivery. Substantial variability and methodological limitations were observed across studies. Conclusion: Cardiac rehabilitation for patients with ANOCA appears safe, acceptable, and associated with meaningful improvements in patient-reported outcomes; however, evidence remains fragmented. Standardized, patient-centred CR models and long-term research are needed to optimize care and inform clinical practice for this underserved population. Registration: Open Science Framework: https://osf.io/nt8xe